Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio
Masoud Mokhtarani, Bruce F. Scharschmidt, Andreas Schulze(University of Toronto), Uta Lichter‐Konecki(University of Pittsburgh), Klara Dickinson, Marwan Ghabril, Douglas Milikien, John M. Vierling(Baylor College of Medicine), George A. Díaz(Icahn School of Medicine at Mount Sinai), Dion F. Coakley, William Berquist(Palo Alto University), Catherine J. Norris, Robert E. Gallagher(Musgrave Park Hospital), Don C. Rockey(Medical University of South Carolina), Wendy E. Smith(Maine Medical Center), Cynthia LeMons(National Urea Cycle Disorders Foundation), B Lee(Baylor College of Medicine), Tristen Moors, P. Mantry(Methodist Dallas Medical Center), Nicola Longo(Center for Human Genetics), Annette Feigenbaum(Hospital for Sick Children), Shawn E. McCandless(University Hospitals of Cleveland), James Bartley(MemorialCare Long Beach Medical Center), S.C. Nagamani(Baylor College of Medicine), Robert S. Brown(Washington University Medical Center), Susan A. Berry(University of Minnesota), C Harding(Oregon Health & Science University), William J. Rhead(Children's Hospital of Wisconsin)
Cited by 38
Related Papers
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Liver biopsy†
|Hepatology|2008|1.9k
Cockayne syndrome: Review of 140 cases
|American Journal of Medical Genetics|1992|807
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Phenylalanine hydroxylase deficiency: diagnosis and management guideline
|Genetics in Medicine|2014|718